EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

CAMK1D as a potential therapeutic target for gut microbiota-driven promotion of lung adenocarcinoma development

Nuo Yan, Yang Zhang, Silin Wang, Sheng Hu, Liancheng Ruan, Yunzhe Wang, Weiqiang Feng, Wenxun Xiong, Wenxiong Zhang, Yiping Wei, Chuan Yao

PeerJ · 2026-03-18 · 14 · e20985

DOI: 10.7717/peerj.20985 ↗

At a glance

Journal article in PeerJ, published online on 2026-03-18. Written by Nuo Yan and 10 co-authors. Institution: Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China. Major MEDLINE topics: Lung Neoplasms, Adenocarcinoma of Lung, Calcium-Calmodulin-Dependent Protein Kinase Type 1, Gastrointestinal Microbiome. 56 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Science and Technology Plan of Jiangxi Provincial Health Commission, Key Research and Development Program of Jiangxi Province.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

The gut microbiome is closely associated with malignant tumors; however the specific mechanisms by which it contributes to the development of lung adenocarcinoma remain unclear. In this study, we performed a two-sample bidirectional Mendelian randomization (MR) analysis to assess the causal relationship between the gut microbiome and lung adenocarcinoma. By identifying single nucleotide polymorphism markers linked to gut microbiome species, we aimed to discover potential biomarkers for lung adenocarcinoma. These findings may offer new insights into the role of the gut microbiome in the prevention and treatment of lung adenocarcinoma.

Methods

We used genome-wide association study (GWAS) summary statistics to assess the association between the gut microbiome and lung adenocarcinoma through two-sample MR analysis. Sensitivity analyses were performed to confirm the robustness of the findings. Reverse MR analysis and GWAS data integration were employed to identify potential genetic and therapeutic targets. Bioinformatics analysis and quantitative Real-Time PCR (qRT-PCR) were utilized to validate gene expression and explore the underlying mechanisms of key genes.

Results

Our analysis identified two bacterial taxa, Prevotella9 and Parabacteroides, as being causally associated with lung adenocarcinoma, both showing positive causal relationships. Sensitivity analyses confirmed the robustness of these associations. The reverse MR analysis revealed no evidence of reverse causality. GWAS data identified 15 genes (DNAH1, PDE10A, DOCK2, INSYN2B, DNAI3, SUOX, LINC01505, SULT4A1, NT5ELP, LINC02895, calcium/calmodulin dependent protein kinase 1D (CAMK1D), ENSG00000253557, BCAS3, C18orf63, MYO18B) that passed the summary-data-based MR test. The transcriptomic data revealed that five genes (CAMK1D, BCAS3, DNAH1, PDE10A, and C18orf63) were differentially expressed between lung adenocarcinoma patients and healthy individuals. Through qRT-PCR validation, the CAMK1D gene was markedly upregulated in lung adenocarcinoma cell lines, whereas BCAS3, DNAH1, PDE10A, and C18orf63 genes exhibit ed substantially reduced expression.

Conclusion

Our study identified specific gut microbial taxa as risk factors for lung adenocarcinoma and proposes CAMK1D as a microbiota-related candidate biomarker and potential therapeutic target that may inform personalized treatment and drug development strategies in the future.

Subjects

MeSH terms (MEDLINE)

Lung NeoplasmsAdenocarcinoma of LungCalcium-Calmodulin-Dependent Protein Kinase Type 1Gastrointestinal MicrobiomeHumansPolymorphism, Single NucleotideGenome-Wide Association StudyMendelian Randomization AnalysisPrevotellaGene Expression Regulation, Neoplastic

Author keywords

Gut microbiotaLung adenocarcinomaMendelian randomizationSingle-cell RNA-seqTranscriptomics

Substances

Calcium-Calmodulin-Dependent Protein Kinase Type 1CAMK1D protein, human

Authors and institutions

  • Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Department of Thoracic Surgery, Affiliated Hospital of Jiujiang University, Jiujiang, China.

Funding

  • National Natural Science Foundation of China
  • Science and Technology Plan of Jiangxi Provincial Health Commission
  • Key Research and Development Program of Jiangxi Province
  • Jiangxi Province Graduate Innovation Fund Project

Cite

APA

Yan, N., Zhang, Y., Wang, S., Hu, S., Ruan, L., Wang, Y., Feng, W., Xiong, W., Zhang, W., Wei, Y., & Yao, C. (2026). CAMK1D as a potential therapeutic target for gut microbiota-driven promotion of lung adenocarcinoma development. PeerJ, 14, e20985. https://doi.org/10.7717/peerj.20985

Vancouver

Yan N, Zhang Y, Wang S, Hu S, Ruan L, Wang Y, et al. CAMK1D as a potential therapeutic target for gut microbiota-driven promotion of lung adenocarcinoma development. PeerJ. 2026;14:e20985. doi:10.7717/peerj.20985

BibTeX
@article{Yan2026,
  author = {Yan, Nuo and Zhang, Yang and Wang, Silin and Hu, Sheng and Ruan, Liancheng and Wang, Yunzhe and Feng, Weiqiang and Xiong, Wenxun and Zhang, Wenxiong and Wei, Yiping and Yao, Chuan},
  title = {CAMK1D as a potential therapeutic target for gut microbiota-driven promotion of lung adenocarcinoma development},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e20985},
  doi = {10.7717/peerj.20985}
}
Start for free →